GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice

Journal of Clinical Investigation

Volumn 102, Issue 9, 1998, Pages 1704-1714

  Stämpfli, Martin R ^a   Wiley, Ryan E ^a   Neigh, G Scott ^a   Gajewska, Beata U ^a   Lei, Xue Feng ^a   Snider, Denis P ^a   Xing, Zhou ^a   Jordana, Manel ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Airway inflammation; Eosinophils; GM CSF; Mice; Ovalbumin

Indexed keywords

CD69 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN;

ADENOVIRUS; AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; GOBLET CELL; LEUKOCYTE MIGRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; T LYMPHOCYTE; TRANSGENE;

EID: 0032211803     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4160     Document Type: Article

References (51)

1. Jansen, H.M. 1996. The role of alveolar macrophages and dendritic cells in allergic airways sensitization. Allergy. 51:279-292.
2. Bienenstock, J. 1984. Bronchus-associated lymphoid tissue. In Immunology of the Lung and Upper Respiratory Tract. J. Bienenstock, editor. McGraw-Hill Book Co., Montreal. 96-118.
3. Bradley, B.L., M. Azzawi, M. Jacobson, B. Assoufi, J.V. Collins, A.M. Irani, L.B. Schwartz, S.R. Durham, P.K. Jeffery, and A.B. Kay. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88: 661-674.
4. Djukanovic, R., W.R. Roche, J.W. Wilson, C.R.W. Beasley, O.P. Twentyman, P.H. Howarth, and S.T. Holgate. 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:434-457.
5. Corrigan, C.J., and A.B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today. 13:501-507.
6. Robinson, D.S., Q. Hamid, S. Ying, A. Tricopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay. 1992. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
7. Bentley, A.M., Q. Meng, D.S. Robinson, Q. Hamid, A.B. Kay, and S.R. Durham. 1993. Increases in activated T lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
8. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J. Exp. Med. 178:889-899.
9. McMenamin, C., C. Pimm, M. McKersey, and P.G. Holt. 1994. Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science. 265:1869-1871.
10. van Halteren, A.G., M.J. van der Cammen, D. Cooper, H.F. Savelkoul, G. Kraal, and P.G. Holt. 1997. Regulation of antigen-specific IgE, IgG1, and mast cell responses to ingested allergen by mucosal tolerance induction. J. lmmunol. 159:3009-3015.
11. Renz, H., H.R. Smith, J.E. Henson, B.S. Ray, C.G. Irvin, and E.W. Gelfand. 1992. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J. Allergy Clin. Immunol. 89:1127-1138.
12. Holt, P.G., and C. McMenamin. 1989. Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin. Exp. Allergy. 19: 255-262.
13. Herscowitz, H.B. 1985. In defense of the lung: paradoxical role of the pulmonary alveolar macrophage. Ann. Allergy. 55:634-650.
14. Bilyk, N., and P.G. Holt. 1993. Inhibition of immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 177:1773-1777.
15. Metcalf, D. 1986. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood. 67:257-267.
16. Morrissey, P.J., L. Bressler, L.S. Park, A. Alpert, and S. Gillis. 1987. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139:1113-1119.
17. Fischer, H.-G., S. Frosch, K. Reske, and A.B. Reske-Kunz. 1988. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augment antigen presentation function. J. Immunol. 141:3882-3888.
18. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor. J. Exp. Med. 179:1109-1118.
19. Chang, C.-H., M. Furue, and K. Tamaki. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Eur. J. Immunol. 25:394-398.
20. Tao, M.-H., and R. Levy. 1993. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature. 362:755-758.
21. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R.C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:3539-3543.
22. Disis, M.L., H. Bernhard, F.M. Shiota, S.L. Hand, J.R. Gralow, E.S. Huseby, S. Gillis, and M.A. Cheever. 1996. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood. 88:202-210.
23. Ellem, K.A., M.G. O'Rourke, G.R. Johnson, G. Parry, I.S. Misko, C.W. Schmidt, P.G. Parsons, S.R. Burrows, S. Cross, A. Fell, et al. 1997. A case report: immune responses and clinical course of the first human use of granulocyte-macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunol. Immunother. 44:10-20.
24. Simons, J.W., E.M. Jaffee, C.E. Weber, H.I. Levitsky, W.G. Nelson, M.A. Carducci, A.J. Lazenby, L.K. Cohen, C.C. Finn, S.M. Clift, et al. 1997. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res. 57:1537-1546.
25. Seelentag, W.K., J.-J. Mermod, R. Montesano, and P. Vassalli. 1987. Additive effects of interleukin 1 and tumor necrosis factor-α on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNA in human endothelial cells. EMBO (Eur. Mol. Biol. Organ.) J. 6:2261-2265.
26. Xing, Z., M. Jordana, T. Braciak, T. Ohtoshi, and J. Gauldie. 1993. Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. Am. J. Respir. Cell Mol. Biol. 9:255-263.
27. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 4:15-24.
28. + T cells in major histocompatibility complex class II-deficient mice. Science. 253:1417-1420.
29. Xing, Z., Y. Ohkawara, M. Jordana, F.L. Graham, and J. Gauldie. 1996. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest. 97: 1102-1110.
30. Bett, A.J., W. Haddara, L. Prevec, and F.L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA. 91:8802-8806.
31. Ohkawara, Y., X.-F. Lei, M.R. Stämpfli, J.S. Marshall, Z. Xing, and M. Jordana. 1997. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am. J. Respir. Cell Mol. Biol. 16:510-520.
32. Lei, X.-F., Y. Ohkawara, M.R. Stämpfli, J. Gauldie, K. Croitoru, M. Jordana, and Z. Xing. 1998. Compartmentalized transgene expression of granulocyte-macrophage colony stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation. Clin. Exp. Immunol. 113:157-165.
33. Kung, T.T., D.M. Stelts, J.A. Zurcher, G.K. Adams III, R.W. Egan, W. Kreutner, A.S. Watnick, H. Jones, and R.W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. Respir. Cell Mol. Biol. 13:360-365.
34. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs. J. Immunol. 159:565-573.
35. -) cells and Th-1 delayed-type hypersensitivity effector T cells. J. Immunol. 146:3322-3331.
36. Ziegler, S.F., F. Ramsdell, and M.R. Alderson. 1994. The activation antigen CD69. Stem Cell. 12:456-465.
37. Kung, T.T., H. Jones, G.K. Adams, III, S.P. Umland, W.R. Kreutner, W. Egan, R.W. Chapman, and A.S. Watnick. 1994. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 105:83-90.
38. Manfreda, J., A.B. Becker, P.-Z. Wang, L.L. Roos, and N.R. Anthonisen. 1993. Trends in physician-diagnosed asthma prevalence in Manitoba between 1980 and 1990. Chest. 103:151-157.
39. Farber, H.J., W. Wattigney, and G. Berenson. 1997. Trends in asthma prevalence: the Bogalusa heart study. Ann. Allergy Asthma Immunol. 78:265-269.
40. Lang, R.A., D. Metcalf, R.A. Cuthbertson, I. Lyons, E. Stanley, A. Kelso, G. Kannourakis, D.J. Williamson, G.K. Klintworth, T.J. Gonda, and A.R. Dunn. 1987. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulation of macrophages, blindness, and a fatal syndrome of tissue damage. Cell. 51:675-686.
41. + T cells. J. Immunol. 159:591-598.
42. Churchill, L., B. Friedman, R.P. Schleimer, and D. Proud. 1992. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology. 75:189-195.
43. Ohtoshi, T., T. Tsuda, C. Vanchieri, J.S. Abrams, J. Gauldie, J. Dolovich, J.A. Denburg, and M. Jordana. 1991. Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells. Int. Arch. Allergy Appl. Immunol. 95:376-384.
44. Vanchieri, C., J. Gauldie, J. Bienenstock, G. Cox, R. Scicchitano, A. Stanisz, and M. Jordana. 1989. Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am. J. Respir Cell. Mol. Biol. 1:289-295.
45. Thorens, B., J.-J. Mermod, and P. Vasalli. 1987. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttran-scriptional regulation. Cell. 48:671-679.
46. Pattemore, P.K., S.L. Johnston, and P.G. Bardin. 1992. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin. Exp. Allergy. 22:325-336.
47. Cypcar, D., and W.W. Busse. 1993. Role of viral infections in asthma. Immunol. Allergy Clin. N. Am. 13:745-767.
48. Sakamoto, M., S. Ida, and T. Takishima. 1984. Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice. J. lmmunol. 132:2614-2617.
49. Holt, P.G., J. Vines, and N. Bilyk. 1988. Effect of influenza virus infection on allergic sensitization to inhaled antigen in mice. Int. Arch. Allergy Appl. Immun. 86:121-123.
50. Woolley, K.L., E. Adelroth, M.J. Woolley, R. Ellis, M. Jordana, and P.M. O'Byrne. 1994. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. Eur. Respir. J. 7:1576-1584.
51. Ohno, I., R. Lea, S. Finotto, J. Marshall, J. Denhurg, J. Dolovich, J. Gauldie, and M. Jordana. 1991. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am. J. Respir. Cell Mol. Biol. 5:505-510.